Madrigal Pharmaceuticals Inc (MDGL)

Biotech stocks have underperformed in the U.S. stock market by a wide margin this year. The sector's most popular index, the iShares Biotechnology ETF (NASDAQ:IBB),…

3 Biotech Stocks That Wall Street Analysts Can’t Get Enough Of

By Larry Ramer, InvestorPlace Contributor Aug 30, 2023

Worries about biotech stocks are way overdone, so the sector should make a big comeback in the coming months.

The 3 Most Promising Pharma Stocks to Own Now

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Aug 30, 2023

A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride.

Why These 7 Healthcare Stocks Could Soar in 2023

By Muslim Farooque, InvestorPlace Contributor Jan 2, 2023

These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023.

7 Drug Stocks That Will Soar in 2023

By Larry Ramer, InvestorPlace Contributor Dec 22, 2022

These drug stocks to buy look poised to generate huge profits for investors., both in 2023 and in subsequent years.

Why Is Madrigal Pharmaceuticals (MDGL) Stock Up 216% Today?

By William White, InvestorPlace Writer Dec 19, 2022

Madrigal Pharmaceuticals (MDGL) stock is rocketing higher on Monday after sharing positive results from its NASH treatment.

5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH

By Aaron Levitt, InvestorPlace Contributor Sep 26, 2018

Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.

4 Biotech Stocks With Leaky Pipelines

By Regina Borsellino Apr 10, 2018

A strong pipeline can make or break biotech stocks, ensuring strong profits for years to come. These four biotech companies don't make the cut.

Is Madrigal Pharmaceuticals Stock a Buy?

From The Motley Fool May 21, 2024

It's not the most prominent biotech, but it has an important claim to fame.

2 Under-the-Radar Growth Stocks to Consider

From The Motley Fool Apr 10, 2024

Don't ignore these innovative companies.

Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics

From The Motley Fool Apr 5, 2024

These businesses should see good times ahead.

1 No-Brainer Growth Stock to Buy Now

From The Motley Fool Apr 3, 2024

This liver-disease specialist might be significantly undervalued.

Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals

From The Motley Fool Mar 29, 2024

Both stocks are pretty risky, but one of them more so than the other.

Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval?

From The Motley Fool Mar 29, 2024

Could it be just a matter of time before Madrigal Pharmaceuticals stock takes off?

Madrigal Pharmaceuticals Inc (MDGL)

MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024

7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024

The 3 Best Biotech Stocks to Buy in April 2024

7 Biotech Stocks Ready to Ride the Sector’s Resurgence

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Madrigal Pharmaceuticals Inc (MDGL)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MDGL Stock Predictions, Articles, and Madrigal Pharmaceuticals Inc News

Subscriber Sign in